Navigation Links
MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
Date:6/17/2008

WARRENDALE, Pa., June 17 /PRNewswire/ -- MEDRAD, INC., announced today that it received FDA 510(k) clearance for a new Fluorodeoxyglucose (FDG) Infusion System for Positron Emission Tomography/Computed Tomography (PET/CT) imaging procedures. The new Intego(TM) PET Infusion System is the first infusion system available in the United States to automate the FDG delivery process.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )

In automating and controlling the FDG delivery process, the Intego System enables the healthcare provider to easily administer FDG at any time throughout the day and enhances the clinician's ability to deliver FDG with precision, flexibility, and safety.

The Intego System automatically extracts a patient dose from a multi-dose vial and delivers it directly to the patient, virtually eliminating manual dose preparation and handling, and the corresponding radiation exposure to the technologist. With the Intego System's dose-on-demand capability, the prescribed dose can be delivered when the patient and technologist are ready, enabling technologists to easily and efficiently respond to schedule changes, patient delays, and add-on patients. Innovative features, including real-time dose availability information, an integrated ionization chamber, and an optional weight-based dose calculation, allow the healthcare provider to more precisely customize each patient's dose. Safety features include a tungsten multi-dose vial shield, a fully lead-lined mobile cart, and an automated saline flush to remove residual FDG from the line after each infusion.

"MEDRAD has a strong heritage of developing innovative products to improve fluid delivery for Cardiovascular (CV), Magnetic Resonance (MR) and Computed Tomography (CT) imaging procedures. With our new Intego system that fully automates FDG delivery, we can once again improve how
'/>"/>

SOURCE MEDRAD, INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MEDRAD(R) XDS(TM) Extravasation Detector Wins Medical Design Excellence Award
2. MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector
3. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
4. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
5. Xenon Receives BIOTECanada Gold Leaf Award
6. Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
7. Advance Nanotechs Owlstone Subsidiary Receives Order From IEE
8. Met-Pro Corporations Fybroc Business Unit Receives Equipment Order Totaling Approximately $500,000
9. CryoLifes BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
10. Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
11. Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
(Date:1/14/2014)... 2014 iLab Solutions, the leader in core ... Director of Product Strategy. In this role, Michelle will work ... to guide in the development of iLab products. Her main ... possible benefit to the scientific community by offering the most ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... 30 DOR BioPharma, Inc. (OTC Bulletin Board: SNGX), a ... corporate name change from DOR BioPharma, Inc. to Soligenix, Inc. ... change, the Company,s shares of common stock will immediately begin ... , "We are pleased to announce the name ...
... STOCKHOLM, September 30 Nobelprize.org has ... official news about the 2009,Nobel Prize Announcements as soon as ... or Medicine, will be made on October 5, (see,the full ... exact,moment the announcements are made public in the following ways: ...
... 30 Amicus Therapeutics (Nasdaq: FOLD ) today announced ... (1-deoxynojirimycin HCl), its investigational drug in development for the treatment ... is to evaluate the pharmacokinetics of AT2220 in muscle tissue ... Administration (FDA) has agreed to Amicus, proposal for the Phase ...
Cached Biology Technology:DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 2DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 3DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 4Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements 2Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements 3Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 2Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 3Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 4
(Date:4/17/2014)... consumption advisories for expecting mothers are ineffective in ... organic pollutants (POPs). , The study, performed ... Toronto Scarborough PhD student Matt Binnington and Professor ... environmental contamination, a mother,s compliance with advisories, and ... exposure in her children. , Their model estimates ...
(Date:4/17/2014)... in about one per eight hundred births, Down syndrome ... genetic cause of intellectual disability. It results from a ... third copy of chromosome 21 (1% of the human ... team in the Department of Genetic Medicine and Development ... published in Nature , shed light on how ...
(Date:4/17/2014)... to produce hydrogen sulfide in order to properly multiply ... from the Center for Craniofacial Molecular Biology at the ... Songtao Shi, principal investigator on the project, said the ... the flow of calcium ions. The essential ions activate ... or the creation of new bone tissue, and keeps ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3
... released by the University of Minnesota Boynton Health Service ... nation to conduct a comprehensive survey on the health ... survey. Although the study is focused on students from ... national health trends for college students, says Dr. Ed ...
... 25% of Europes medium sized household appliances and 40% ... leaving substantial room for improvement, according to a study ... consortium. Small appliances, with a few exceptions, are close ... long-term collection rate targets of around 60% for small ...
... -- In response to the need for localized efforts ... threatened staghorn coral, Diego Lirman, Ph.D., and James Herlan, ... Marine and Atmospheric Science (RSMAS) have established an ... The goals of the coral nursery are to ...
Cached Biology News:University of Minnesota releases first ever comprehensive report of the health of college students 2University of Minnesota releases first ever comprehensive report of the health of college students 3University of Minnesota releases first ever comprehensive report of the health of college students 4University of Minnesota releases first ever comprehensive report of the health of college students 5Great potential to improve collection, recycling of Europe's electronic waste, says UN report 2Great potential to improve collection, recycling of Europe's electronic waste, says UN report 3New south Florida nursery to focus on staghorn corals 2